> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Majority of PMRs/PMCs On Schedule: Report
- URL: https://www.fdaweb.com/majority-of-pmrs-pmcs-on-schedule-report/
- Published: 2020-08-06T12:00:00.000Z
- Updated: 2026-09-14T16:24:13.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147368

The FDA FY 2019 annual [report](https://www.fda.gov/media/140827/download?utm%5Fcampaign=FDA%20Issues%20Annual%20Report%20on%20the%20Status%20of%20PMRs%20and%20PMCs&utm%5Fmedium=email&utm%5Fsource=Eloqua) on the status of postmarketing requirements (PMRs) and postmarketing commitments (PMCs) shows that the majority of the requirements and commitments were completed or are moving toward completion according to the original schedule. “Very few PMRs/PMCs are ‘delayed,’” the agency says in a [statement](http://s2027422842.t.en25.com/e/es?s=2027422842&e=360236&elqTrackId=376c7bc788024cd5a73d955f2e3dcbdc&elq=64d83120e43b45b69d8291a942fff950&elqaid=13679&elqat=1&ref=fdaweb.com) announcing the availability of the report. “FDA is committed to ensuring that PMRs and PMCs, which further describe the safety, efficacy, and/or optimal use of a drug, are conducted and reported as required.”